Bank of Montreal
ATOS icon

Bank of Montreal’s Atossa Therapeutics ATOS Stock Holding History

Bank of Montreal’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-23,513
Closed -$360K – 3878
2023
Q4 		$360K Buy
+23,513
New +$254K ﹤0.01% 2745
2023
Q1 		– Sell
-11,713
Closed -$105K – 3785
2022
Q4 		$105K Buy
+11,713
New +$135K ﹤0.01% 3354
2022
Q3 		– Sell
-20,640
Closed -$365 – 4070
2022
Q2 		$365 Buy
+20,640
New +$325K ﹤0.01% 2886
2021
Q2 		– Sell
-67
Closed -$2K – 3730
2021
Q1 		$2K Buy
+67
New +$2.45K ﹤0.01% 4888

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Bank of Montreal's ATOS Position: Q1 2024 in Review

Bank of Montreal sold out of Atossa Therapeutics (ATOS) in Q1 2024, closing a stake of 23,513 shares — an estimated $360K sold.

Bank of Montreal first reported a position in ATOS in Q1 2021 and held it in 4 quarters. The position peaked at $360K in Q4 2023. 67 funds tracked by Wall St. Rank hold ATOS as of Q1 2024.

  • Bank of Montreal reported no remaining Atossa Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 23,513 Atossa Therapeutics shares in Q1 2024, an estimated $360K.
  • Bank of Montreal first reported a position in Atossa Therapeutics in Q1 2021 and held it in 4 quarters.
  • Bank of Montreal's Atossa Therapeutics position peaked at $360K in Q4 2023.
  • 67 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.